[Clinical experience with benzene sulfonyl chloride (author's transl)].
The clinical development of a percutaneous benzene sulfonyl chloride absorption, which can also occur on the mucous membrane, has a biological effect on the skin and results in reversible toxic damage to the liver; three such cases are described. Two patients experienced very severe shock which was brought under control after 1 to 1.5 hrs. A possible allergic genesis reaction of an immediate type is discussed.
D000062:Accidents, Occupational; D000328:Adult; D001555:Benzene Derivatives / Q000009:adverse effects*; D001986:Bronchial Spasm / Q000139:chemically induced; D002057:Burns, Chemical / Q000209:etiology*; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology; D003231:Conjunctivitis / Q000139:chemically induced; D005126:Eye Burns / Q000139:chemically induced; D006801:Humans; D007073:Immunoglobulin E / Q000032:analysis; D008297:Male; D008875:Middle Aged; D012772:Shock, Septic / Q000209:etiology; D012869:Skin Absorption; D013450:Sulfones / Q000009:adverse effects*; D014581:Urticaria / Q000139:chemically induced
D001555:Benzene Derivatives; D013450:Sulfones; D007073:Immunoglobulin E
Klinische Erfahrung mit Benzolsulfonsäurechlorid